Medical Properties Trust, Inc.
NYSE:MPTREIT - Healthcare Facilities
-$0.02 today
- Market cap
- $959.91M
- Beta
- 1.46
- P/E (TTM)
- -22.0
- EPS (TTM)
- -$0.21
- Dividend yield
- 7.55%
Volume 29.38M
Average 5.52M
MPT Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Medical Properties Trust, Inc.NYSE: MPT
Gross Margin · Q2 FY2026 · quarter ended Jun 2026
Gross margin widens to 100.0%
Gross margin was 100.0% in Q2 FY2026, up 4.5 pp from a year earlier. On a trailing-twelve-month basis it was 97.2%, up 0.7 pp year over year. Over 3 fiscal years it narrowed by 0.8 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 96.3%
- Year-over-year change
- -1.0pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 96.3% | -1.0pp |
| FY2024 | 2024-12-31 | 97.3% | +2.0pp |
| FY2023 | 2023-12-31 | 95.2% | -1.8pp |
| FY2022 | 2022-12-31 | 97.0% | -0.4pp |
| FY2021 | 2021-12-31 | 97.5% | — |
Gross Margin vs competitors
How MPT compares with its peers on the latest reported figures
- MPT's LTM Jun 2026 gross margin of 97.2% is the highest of the 9 companies compared; the peer median is 53.5%.
- Its year-over-year change of +0.7 pp is the highest of 9, against a peer median of -32.4 pp.
- Over three fiscal years its change of -0.8 pp compares with a peer median of -25.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | 97.2% | +0.7 pp | -0.8 pp |
| LTM Jun 2026 | 72.0% | -26.8 pp | -53.7 pp | |
| LTM Sep 2026 | 64.7% | -18.7 pp | -16.0 pp | |
| LTM Jun 2026 | 61.8% | -5.5 pp | -9.0 pp | |
| LTM Jun 2026 | 54.2% | -1.8 pp | -31.4 pp | |
| LTM Jun 2026 | 52.8% | -39.1 pp | -66.1 pp | |
| LTM Sep 2026 | 44.5% | -48.1 pp | -3.4 pp | |
| LTM Sep 2026 | 41.8% | -38.0 pp | -19.5 pp | |
| LTM Sep 2026 | -15.1% | -75.2 pp | -35.6 pp | |
| Peer median (excluding MPT) | 53.5% | -32.4 pp | -25.5 pp | |
Competitors are the stored peer set for MPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.54B | 1.54B | 871.8M | 995.55M | 972.02M |
| Cost of Revenue | 39.1M | 45.7M | 41.57M | 27.26M | 36.42M |
| Gross Profit | 1.51B | 1.5B | 830.23M | 968.29M | 935.61M |
| Gross Margin | 97.5% | 97.0% | 95.2% | 97.3% | 96.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 145.64M | 160.49M | 145.59M | 133.79M | 130.43M |
| Operating Expenses | 466.89M | 493.47M | 748.95M | 581.45M | 395.83M |
| Depreciation & Amortization | 333.78M | 345.58M | 616.13M | 453.75M | 272.82M |
| EBITDA | 1.46B | 1.67B | 340.24M | (1.49B) | 545.86M |
| EBITDA Margin | 94.5% | 108.5% | 39.0% | -149.5% | 56.2% |
| Operating Income | 1.04B | 1B | 81.28M | 386.85M | 539.78M |
| Operating Margin | 67.2% | 65.1% | 9.3% | 38.9% | 55.5% |
| Interest Income | 0 | 0 | 0 | 0 | 39.74M |
| Interest Expense | 395.04M | 368.49M | 410.89M | 422.12M | 510.36M |
| Other Income / Expenses | (307.8M) | (43.96M) | (768.06M) | (2.75B) | (777.09M) |
| Income Before Tax | 730.89M | 959.72M | (686.77M) | (2.36B) | (237.32M) |
| Pre-Tax Margin | 47.3% | 62.2% | -78.8% | -237.5% | -24.4% |
| Income Tax Expense | 73.95M | 55.9M | (130.68M) | 44.1M | 38.62M |
| Net Income | 656.02M | 902.6M | (556.48M) | (2.41B) | (277.05M) |
| Net Margin | 42.5% | 58.5% | -63.8% | -242.1% | -28.5% |
| EPS (Basic) | 1.11 | 1.50 | (0.93) | (4.02) | (0.46) |
| EPS (Diluted) | 1.11 | 1.50 | (0.93) | (4.02) | (0.46) |
| Weighted Avg Shares | 588.82M | 598.63M | 598.52M | 600.32M | 600.89M |
| Weighted Avg Shares (Diluted) | 590.14M | 598.84M | 598.52M | 600.32M | 600.89M |
Medical Properties Trust, Inc.
NYSE:MPT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.